Phase IIT Trial of SNA009 (NCT07597759) | Clinical Trial Compass
CompletedEarly Phase 1
Phase IIT Trial of SNA009
China12 participantsStarted 2025-10-30
Plain-language summary
This clinical trial is a single-center, open-label, dose-escalation study designed to evaluate the safety, tolerability, pharmacokinetics and radiation dosimetry of 68Ga-NODAGA-SNA009 in patients with colorectal cancer.
Who can participate
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Aged between 18 and 75 years (inclusive);
. Participants must have legal capacity, voluntarily agree to participate in this clinical trial, and have signed an informed consent form (ICF);
. Patients with a confirmed diagnosis of colorectal cancer;
. Results of colonoscopy, CT, MRI or PET-CT scans performed within the past month (if available);
. Pathology test results from within the past year
Exclusion criteria
. Patients with other clearly diagnosed malignant tumours;
. Patients with uncontrolled severe infections, or those with other serious comorbidities;
. Patients with a life expectancy of ≤3 months;
. Pregnant or breastfeeding patients, and patients of childbearing potential who refuse to use appropriate contraception during the trial;
. Patients deemed unsuitable for participation in this study by the investigator.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
The safety and tolerability in patients with advanced colorectal cancer.
Timeframe: 1 week
2
The safety and tolerability in patients with advanced colorectal cancer.
Timeframe: 1 week
3
The safety and tolerability in patients with advanced colorectal cancer.
Timeframe: 1 week
4
The safety and tolerability in patients with advanced colorectal cancer.
Timeframe: 1 week
5
The safety and tolerability in patients with advanced colorectal cancer.
Timeframe: 1 week
6
The radiation characters in patients with colorectal cancer
Timeframe: 4 hours
7
The biodistribution characteristics of 68Ga-NODAGA-SNA009